10th week of 2017 patent applcation highlights part 7 |
Patent application number | Title | Published |
20170065501 | NITRIDE-BASED NANOPARTICLES FOR USE IN SUNSCREEN APPLICATIONS | 2017-03-09 |
20170065502 | ANTI-REFLECTIVE COATING ON OXIDE PARTICLES FOR SUNSCREEN APPLICATIONS | 2017-03-09 |
20170065503 | NOTCH FILTER COATINGS FOR USE IN SUNSCREEN APPLICATIONS | 2017-03-09 |
20170065504 | IMPLEMENTING ORGANIC MATERIALS IN SUNSCREEN APPLICATIONS | 2017-03-09 |
20170065505 | CONTROLLING ZINC OXIDE PARTICLE SIZE FOR SUNSCREEN APPLICATIONS | 2017-03-09 |
20170065506 | DOPING OF ZINC OXIDE PARTICLES FOR SUNSCREEN APPLICATIONS | 2017-03-09 |
20170065507 | Plasmonic Enhancement of Zinc Oxide Light Absorption for Sunscreen Applications | 2017-03-09 |
20170065508 | Plasmonic Enhancement of Zinc Oxide Light Absorption for Sunscreen Applications | 2017-03-09 |
20170065509 | FAT OR OIL EXTRACT OF BLACK GINGER AND METHOD FOR PRODUCING SAME | 2017-03-09 |
20170065510 | PHOTOSTABLE SUNSCREEN COMPOSITION FOR TOPICAL APPLICATION | 2017-03-09 |
20170065511 | PROCESS FOR PRODUCING A CONDITIONING PRESHAVE OR AFTERSHAVE COMPOSITION | 2017-03-09 |
20170065512 | Film Forming Composition | 2017-03-09 |
20170065513 | Mascara Composition | 2017-03-09 |
20170065514 | CROSS-LINKED COMPOSITION AND COSMETIC COMPOSITION COMPRISING THE SAME | 2017-03-09 |
20170065515 | COMPOSITIONS, METHODS, AND KITS FOR CLEANSING AND MOISTURIZING | 2017-03-09 |
20170065516 | COFFEE CHERRY COSMETIC COMPOSITION AND METHODS | 2017-03-09 |
20170065517 | COMPOSITIONS FOR DELIVERING HYPNOTIC AGENTS ACROSS THE ORAL MUCOSA AND METHODS OF USE THEREOF | 2017-03-09 |
20170065518 | PHARMACEUTICAL SOLUTION FORMULATIONS FOR PRESSURISED METERED DOSE INHALERS | 2017-03-09 |
20170065519 | DRUG-DELIVERING COMPOSITE STRUCTURES | 2017-03-09 |
20170065520 | STABLE LIPOSOMAL FORMULATIONS OF RAPAMYCIN AND RAPAMYCIN DERIVATIVES FOR TREATING CANCER | 2017-03-09 |
20170065521 | BIOPHARMA APPLICATION OF MICELL TECHNOLOGY | 2017-03-09 |
20170065522 | PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF OVERACTIVE BLADDER | 2017-03-09 |
20170065523 | MULTIFUNCTIONAL NANOPARTICLE SYSTEMS AND METHODS FOR CANCER DIAGNOSIS AND COMBINATION THERAPY | 2017-03-09 |
20170065524 | Pharmaceutical Formulation Containing Gelling Agent | 2017-03-09 |
20170065525 | Pharmaceutical Formulation Containing Gelling Agent | 2017-03-09 |
20170065526 | SOLID DOSAGE FORM OF RIVAROXABAN AND METHODS FOR MAKING THE SAME | 2017-03-09 |
20170065528 | Alcohol-Resistant, Dose Dumping Protective Enteric Drug Film Coating | 2017-03-09 |
20170065529 | Pharmaceutical dosage form for immediate release of an indolinone derivative | 2017-03-09 |
20170065530 | UBIQUINOL AND ALPHA LIPOIC ACID COMPOSITIONS | 2017-03-09 |
20170065531 | ALCOHOL-RESISTANT ORAL PHARMACEUTICAL FORM | 2017-03-09 |
20170065532 | VACCINE DELIVERY SYSTEMS USING YEAST CELL WALL PARTICLES | 2017-03-09 |
20170065533 | NANOPARTICLES FOR DERMAL AND SYSTEMIC DELIVERY OF DRUGS | 2017-03-09 |
20170065534 | COMPOSITIONS AND METHODS FOR INTRADERMAL VACCINE DELIVERY | 2017-03-09 |
20170065535 | DEVICE FOR TRANSDERMAL ADMINISTRATION OF DRUGS INCLUDING ACRYLIC BASED POLYMERS | 2017-03-09 |
20170065536 | Induced Expression of Brain Derived Neurotrophic Factor (BDNF) for Treatment of Neuromuscular, Neurodegenerative, Autoimmune, Developmental and/or Metabolic Diseases | 2017-03-09 |
20170065537 | METHOD FOR PRODUCING A FLURANE COMPLEX | 2017-03-09 |
20170065538 | METHODS AND COMPOSITIONS FOR TREATING FATIGUE ASSOCIATED WITH DISORDERED SLEEP USING VERY LOW DOSE CYCLOBENZAPRINE | 2017-03-09 |
20170065539 | METHOD FOR SHORTENING ANTI-INFECTIVE THERAPY DURATION IN SUBJECTS WITH INFECTION | 2017-03-09 |
20170065540 | METHODS AND COMPOSITIONS FOR TREATING INFECTION | 2017-03-09 |
20170065541 | SYNTHESIS AND GROWTH REGULATORY ACTIVITY OF A PROTOTYPE MEMBER OF A NEW FAMILY OF AMINOTHIOL RADIOPROTECTORS | 2017-03-09 |
20170065542 | PHARMACEUTICAL COMPOSITION | 2017-03-09 |
20170065543 | AMINOCYCLOBUTANE DERIVATIVES, METHOD FOR PREPARING SAME AND THE USE THEREOF AS DRUGS | 2017-03-09 |
20170065544 | METHOD OF TREATING IDIOPATHIC PULMONARY FIBROSIS | 2017-03-09 |
20170065545 | COMPOSITIONS AND METHODS FOR THE REDUCTION OR PREVENTION OF HEPATIC STEATOSIS | 2017-03-09 |
20170065546 | COMPOSITIONS CONTAINING AS THE ACTIVE INGREDIENT COMPONENTS FROM SALVIA SCLAREA SEED | 2017-03-09 |
20170065547 | Use Of 2,5-Dihydroxybenzene Compounds And Derivatives For The Treatment Of Skin Cancer | 2017-03-09 |
20170065548 | ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE | 2017-03-09 |
20170065549 | COMPOSITIONS FOR ANTI-INFLAMMATORY, ANTIOXIDANT EFFECTS AND IMPROVED RESPIRATORY FUNCTION BY SPECIFIC HISTONE DEACETYLASE INHIBITION | 2017-03-09 |
20170065550 | PHARMACEUTICAL USE OF 3, 4-BIS-BENZYLSULFONYLBUTYRONITRILE | 2017-03-09 |
20170065551 | Doxepin Trans Isomers And Isomeric Mixtures And Methods Of Using The Same To Treat Sleep Disorders | 2017-03-09 |
20170065552 | OPHTHALMIC FORMULATIONS OF MYCOPHENOLIC ACID | 2017-03-09 |
20170065553 | ORALLY DISPERSIBLE TABLET | 2017-03-09 |
20170065554 | ACTIVATED SOY POD FIBER | 2017-03-09 |
20170065555 | USE OF COUMARIN DERIVATIVES FOR THE PREPARATION OF DRUGS FOR TREATING SKIN DISEASES | 2017-03-09 |
20170065556 | ORAL FORMULATIONS OF PYRROLIDINE DERIVATIVES | 2017-03-09 |
20170065557 | USE OF NK-1 RECEPTOR ANTAGONIST SERLOPITANT IN PRURITUS | 2017-03-09 |
20170065558 | USE OF NK-1 RECEPTOR ANTAGONISTS IN PRURITUS | 2017-03-09 |
20170065559 | INDOLINONE COMPOUNDS AND USES THEREOF | 2017-03-09 |
20170065560 | Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexa- ne-1,1'-pyrano[3,4,b]indo]-4-amine and Antidepressants | 2017-03-09 |
20170065561 | METHODS OF CANCER THERAPY | 2017-03-09 |
20170065562 | THERAPEUTIC AGENT FOR KERATOCONJUNCTIVE DISORDERS | 2017-03-09 |
20170065563 | PROGRESS-SUPRESSING OR IMPROVING AGENT FOR CHRONIC KIDNEY DISEASE | 2017-03-09 |
20170065564 | BIS-CYCLIC GUANIDINE COMPOUND COMPOSITIONS, METHODS OF USE AND TREATMENT THEREOF | 2017-03-09 |
20170065565 | ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND PESTICIDE | 2017-03-09 |
20170065566 | PHARMACEUTICAL COMBINATIONS COMPRISING ANTIBACTERIAL AGENTS | 2017-03-09 |
20170065567 | Pharmaceutical Suspension Composition | 2017-03-09 |
20170065568 | METHODS AND COMPOUNDS FOR CALCIUM ION CHANNEL REGULATION | 2017-03-09 |
20170065569 | Fumarate Analogs and Uses Thereof | 2017-03-09 |
20170065570 | MULTISUBSTITUTED AROMATIC COMPOUNDS AS SERINE PROTEASE INHIBITORS | 2017-03-09 |
20170065571 | PHARMACEUTICAL COMPOSITIONS COMPRISING GLITAZONES AND NRF2 ACTIVATORS | 2017-03-09 |
20170065572 | METHODS OF TREATING DEVELOPMENTAL DISORDERS USING PIPRADROL | 2017-03-09 |
20170065573 | (R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-METHYLBENZ- YL)PYRROLIDIN-2-ONE AND ITS PRODRUGS FOR THE TREATMENT OF PSYCHIATRIC DISORDERS | 2017-03-09 |
20170065574 | INDAZOLE INHIBITORS OF THE WNT SIGNAL PATHWAY AND THERAPEUTIC USES THEREOF | 2017-03-09 |
20170065575 | NAMPT INHIBITORS | 2017-03-09 |
20170065576 | N-ETHYL-N-PHENYL-1,2-DIHYDRO-4,5-DI-HYDROXY-1-METHYL-2-OXO-3-QUINOLINECARB- OXAMIDE, PREPARATION AND USES THEREOF | 2017-03-09 |
20170065577 | THERAPEUTIC COMPOSITIONS AND METHODS | 2017-03-09 |
20170065578 | METHODS FOR TREATING PANCREATIC CANCER USING COMBINATION THERAPIES COMPRISING LIPOSOMAL IRINOTECAN | 2017-03-09 |
20170065579 | Sustained Release Low Dose Formulations and Uses Thereof | 2017-03-09 |
20170065580 | METHODS OF SAFELY TRANSITIONING A SUBJECT TO BUPRENORPHINE | 2017-03-09 |
20170065582 | COMBINATIONS FOR THE TREATMENT OF NEUROBLASTOMA | 2017-03-09 |
20170065583 | TREATMENT OF CANCER WITH DIHYDROPYRAZINO-PYRAZINES | 2017-03-09 |
20170065584 | COMPOSITIONS AND USES THEREOF TO AMELIORATE PAIN | 2017-03-09 |
20170065585 | IMIDAZOLIDINEDIONE DERIVATIVES | 2017-03-09 |
20170065586 | SGC STIMULATORS | 2017-03-09 |
20170065587 | ANTIVIRAL AXIN STABLIZER | 2017-03-09 |
20170065588 | BIOMARKERS FOR PREDICTING SENSITIVITY TO CANCER TREATMENTS | 2017-03-09 |
20170065589 | METHODS OF TREATING OR PREVENTING PRETERM LABOR | 2017-03-09 |
20170065590 | Method of Treating Cancer | 2017-03-09 |
20170065591 | SALTS AND SOLID FORM OF A BTK INHIBITOR | 2017-03-09 |
20170065592 | MODULATORS OF TOLL-LIKE RECEPTORS | 2017-03-09 |
20170065593 | Combination | 2017-03-09 |
20170065594 | POLYFLUORINATED COMPOUNDS ACTING AS BRUTON TYROSINE KINASE INHIBITORS | 2017-03-09 |
20170065595 | USE OF A DPP-4 INHIBITOR IN PODOCYTES RELATED DISORDERS AND/OR NEPHROTIC SYNDROME | 2017-03-09 |
20170065596 | CARDIO- AND RENOPROTECTIVE ANTIDIABETIC THERAPY | 2017-03-09 |
20170065597 | Transient Protection of Normal Cells During Chemotherapy | 2017-03-09 |
20170065598 | METHODS TO TREAT VISUAL IMPAIRMENT | 2017-03-09 |
20170065599 | THERAPY FOR CONSTIPATION | 2017-03-09 |
20170065600 | INHIBITORS OF HUMAN EZH2, AND METHODS OF USE THEREOF | 2017-03-09 |
20170065601 | COMPOSITIONS AND METHODS FOR INHIBITION OF MYCOBACTERIA | 2017-03-09 |
20170065602 | COMPOUNDS WITH TRPV4 ACTIVITY, COMPOSITIONS AND ASSOCIATED METHODS THEREOF | 2017-03-09 |